Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience

Venetoclax-Based Regimens for Relapsed/Refractory Acute Myeloid Leukemia in a Real-Life Setting: A Retrospective Single-Center Experience

Relapsed/refractory (R/R) acute myeloid leukemia (AML) is a largely unmet medical need, owing to the lack of standardized, effective treatment approaches, resulting in an overall dismal outcome. The only curative option for R/R AML patients is allogeneic hematopoietic stem cell transplantation (HSCT...

Full description

Bibliographic Details
Main Authors: Matteo Piccini, Sofia Pilerci, Marta Merlini, Pietro Grieco, Barbara Scappini, Sara Bencini, Benedetta Peruzzi, Roberto Caporale, Leonardo Signori, Fabiana Pancani, Alessandro Maria Vannucchi, Giacomo Gianfaldoni
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Journal of Clinical Medicine
Subjects:
leukemia
venetoclax
chemoresistant
Online Access:https://www.mdpi.com/2077-0383/10/8/1684

Internet

https://www.mdpi.com/2077-0383/10/8/1684

Similar Items